Sector
Synthetic Biology
Discover the early-stage Synthetic Biology ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Synthetic Biology startups.
Discover the early-stage Synthetic Biology ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Synthetic Biology startups.
Scouts
Share promising startups in this sector and get rewarded if they raise. No prior track record needed.
Investors
Access qualified startups curated by Superscout across pre-seed to seed.
Supporters
Work at a company, lab, or city? Connect with builders in your space.
Synthetic biology, a child sector within Superscout's Biotech & Life Sciences category, encompasses the engineering of biological systems to create new organisms, materials, and chemicals, including metabolic engineering, gene synthesis, cell-free systems, and the biomanufacturing platforms that produce everything from sustainable fuels to novel therapeutics to engineered food ingredients. With 3 funders actively investing in synthetic biology startups tracked in Superscout's database, the sector represents one of the most transformative and capital-intensive areas of deep tech.
The synthetic biology investment thesis is that biology is becoming a programmable manufacturing platform: engineered microorganisms can produce chemicals, materials, fuels, and medicines that are currently manufactured from petrochemicals or extracted from natural sources. Companies like Ginkgo Bioworks, Zymergen (acquired by Ginkgo), and Amyris have demonstrated both the potential and the challenges of commercializing synthetic biology at industrial scale.
For synthetic biology founders, the 2025-2026 funding environment rewards companies with validated production organisms, clear paths to manufacturing scale, and specific product applications where bio-manufactured alternatives offer cost, performance, or sustainability advantages over conventional production.
